Lectin, Galactoside-Binding, Soluble, 8 (LGALS8) Kits ELISA

LGALS8 encodes a member of the galectin family. De plus, nous expédions Lectin, Galactoside-Binding, Soluble, 8 Anticorps (139) et Lectin, Galactoside-Binding, Soluble, 8 Protéines (28) et beaucoup plus de produits pour cette protéine.

list all ELISA KIts Gène GeneID UniProt
LGALS8 56048 Q9JL15
LGALS8 3964 O00214
LGALS8 116641  
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top Lectin, Galactoside-Binding, Soluble, 8 Kits ELISA sur anticorps-enligne.fr

Showing 10 out of 58 products:

Catalogue No. Reactivité Sensibilité Gamme Images Quantité Livraison Prix Détails
Humain 7.8 pg/mL 31.25-2000 pg/mL Typical standard curve 96 Tests 15 to 18 Days
$910.56
Détails
Boeuf (Vache) 0.118 ng/mL 0.31 ng/mL - 20 ng/mL 96 Tests 13 to 16 Days
$795.79
Détails
Souris 0.055 ng/mL 0.156 ng/mL - 10 ng/mL 96 Tests 15 to 17 Days
$852.24
Détails
Rat 0.028 ng/mL 0.156 ng/mL - 10 ng/mL 96 Tests 15 to 17 Days
$891.06
Détails
Lapin 0.1 ng/mL 0.5-10 ng/mL   96 Tests 15 to 18 Days
$707.14
Détails
Porc 0.1 ng/mL 1.0-25 ng/mL   96 Tests 15 to 18 Days
$707.14
Détails
Cobaye 0.1 ng/mL 0.5-10 ng/mL   96 Tests 15 to 18 Days
$707.14
Détails
Poulet 0.938 ng/mL 1.563-100 ng/mL   96 Tests 12 to 14 Days
$715.00
Détails
Singe 0.188 ng/mL 0.313-20 ng/mL   96 Tests 12 to 14 Days
$715.00
Détails
Chien 0.1 ng/mL 0.5-10 ng/mL   96 Tests 15 to 18 Days
$707.14
Détails

Plus Kits ELISA pour Lectin, Galactoside-Binding, Soluble, 8 partenaires d'interaction

Mouse (Murine) Lectin, Galactoside-Binding, Soluble, 8 (LGALS8) interaction partners

  1. these findings identify gal-8 as a new physiologic player in the regulation of bone mass.

  2. Galectin-8 regulates antibacterial autophagy through differential recognition of host glycans on damaged phagosomes.

  3. Galectin-8 activates dendritic cells and stimulates antigen-specific immune response elicitation.

  4. these data suggest that Gal-8 promotes the differentiation of highly suppressive Treg cells, which has implications for the treatment of inflammatory and autoimmune diseases.

  5. this study uncovers a unique molecular mechanism of lymphangiogenesis in which galectin-8-dependent crosstalk among VEGF-C, podoplanin and integrin pathways plays a key role.

  6. Gal-8mut was unable to induce T-cell proliferation, but efficiently co-stimulated antigen-specific responses, bothin vitroandin vivo.

  7. Gal-8 emerges as an attractive therapeutic candidate.

  8. Galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice.

  9. Gal-8 stimulated naive T cells, but had an antiproliferative effect when these cells were activated.A dose of recombinant Gal-8 administered with a suboptimal Ag dose to DO11.10 mice strengthened weak responses in vivo.

  10. a novel role for Gal-8 in collaboration with Gal-1 in plasma cell formation, and suggest the possibility of using distinct LacNAc ligands to modulate the function of Gals.

  11. The findings of the present study delineate the differential molecular requirements for Gal-8 activities on T-cells, and suggest a dual activity relying on activation state.

  12. galectin-8 is expressed in the thymus in mouse, which suggests an active role for this lectin in shaping the mature T cell repertoire

  13. Taken together, our findings support a distinctive role for locally produced Gal-8 as an enhancer of otherwise borderline immune responses and also suggest that Gal-8 might fuel the reactivity at inflammatory foci.

Human Lectin, Galactoside-Binding, Soluble, 8 (LGALS8) interaction partners

  1. The study identified Gal-8 as a potent factor in osteoarthritis pathogenesis, acting in concert with Gal-1 and -3.

  2. Inhibition of galectin-8- and NDP52-dependent autophagy increased seeded tau aggregation.

  3. analysis of crystallographic structures of the galectin-8 N-terminal domain (galectin-8N) in complex with LNT and LNnT

  4. Gal-8 served as a new positive prognostic factor for the OS and DFS of ovarian cancer patients.

  5. We further demonstrated using the NMR-based hydrogen-deuterium exchange (HDX) that lactose binding increases the exchange rates of residues located on the opposite side of the ligand-binding pocket for hGal1 and hGal8(NTD), indicative of allostery. Additionally, lactose binding induces significant stabilisation of hGal8(CTD) across the entire domain

  6. findings reveal that differential levels of Gal-3 and Gal-8 expression and recruitment to Group A streptococcus (GAS) between epithelial cells and endothelial cells may contribute to the different outcomes of GAS elimination or survival and growth of GAS in these two types of cells.

  7. the natural and conserved expression of Gal-8 in tumour cells is responsible for the metastatic evolution of prostate cancer.

  8. Both Gal-8 isoforms led to enhanced adhesion of myeloma cells to vascular endothelium under dynamic shear stress conditions, Gal-8L (by more than 40-fold) even stronger than Gal-8S.

  9. Our data indicate that Gal-8 interacts with ALCAM at the surface of breast cancer cells through glycosylation-dependent mechanisms. A novel heterophilic interaction between ALCAM and Gal-8 is demonstrated here, suggesting its physiologic relevance in the biology of breast cancer cells

  10. we detected Gal-8 in human cerebrospinal fluid, suggesting a role in the CNS immune-surveillance circuit. In addition, we show that MS patients generate function-blocking anti-Gal-8 antibodies with pathogenic potential. Furthermore, circulating anti-Gal-8 antibodies associate with relapsing-remitting MS, and not with progressive MS phenotypes, predicting clinical disability at diagnosis within the first year of follow-up

  11. Data suggest that galectin-8 is a potential independent favorable prognostic biomarker for survival and recurrence of patients with gastric cancer after surgery.

  12. this study uncovers a unique molecular mechanism of lymphangiogenesis in which galectin-8-dependent crosstalk among VEGF-C, podoplanin and integrin pathways plays a key role.

  13. Platelet-derived factor V/Va is generated following endocytosis of the plasma-derived molecule by the platelet precursor cells, megakaryocytes, via a two receptor system consisting of LRP-1 and an unidentified specific "binding site".

  14. Gal-8 expression is a potential independent unfavorable prognostic indicator for postoperative recurrence of patients with localized pT1 clear cell renal cell carcinoma

  15. The fundamental roles of galectin-8 in human anaplastic large cell lymphoma

  16. The implications of gal-8 in tumor angiogenesis remain to be further explored, but it is exciting to speculate that modulating gal-8-glycan interactions could be used to block lymphatic-vascular connections vital for metastasis

  17. We integrate here the available information on Gal-8 expression in different tumor types and attempt to elucidate associations of its expression and localization with tumor progression[review]

  18. these results not only confirm the pro-inflammatory role we have already proposed for Gal-8 in other cellular systems but also suggest that this lectin is orchestrating the interaction between leukocytes, platelets and endothelial cells

  19. Whereas Galectin (Gal)-1, -3, and -8 triggered vascular endothelial growth factor (VEGF) release, only Gal-8 induced endostatin secretion.

  20. Focusing on the F19Y change in galectin-8, we study of consequences of a single-site substitution in the carbohydrate recognition domain of this family of cellular effectors.

Lectin, Galactoside-Binding, Soluble, 8 (LGALS8) profil antigène

Antigen Summary

This gene encodes a member of the galectin family. Galectins are beta-galactoside-binding animal lectins with conserved carbohydrate recognition domains. The galectins have been implicated in many essential functions including development, differentiation, cell-cell adhesion, cell-matrix interaction, growth regulation, apoptosis, and RNA splicing. This gene is widely expressed in tumoral tissues and seems to be involved in integrin-like cell interactions. Alternatively spliced transcript variants encoding different isoforms have been identified.

Gene names and symbols associated with LGALS8

  • galectin 8 (LGALS8) anticorps
  • lectin, galactose binding, soluble 8 (Lgals8) anticorps
  • galectin 8 (Lgals8) anticorps
  • lectin, galactoside binding soluble 8 S homeolog (lgals8.S) anticorps
  • 1200015E08Rik anticorps
  • AI326142 anticorps
  • D13Ertd524e anticorps
  • Gal-8 anticorps
  • galectin-8 anticorps
  • Lgals-8 anticorps
  • LGALS8 anticorps
  • PCTA-1 anticorps
  • PCTA1 anticorps
  • Po66-CBP anticorps
  • xgalectin-VIIIa anticorps

Protein level used designations for LGALS8

lectin, galactoside-binding, soluble, 8 , lectin, galactoside-binding, soluble, 8 (galectin 8) , galectin-8-like , gal-8 , galectin 8 , galectin-8 , galectin-8L , lectin, galactose binding, soluble 5 , galectin-8 variant II , Po66 carbohydrate binding protein , galectin-8g , po66 carbohydrate-binding protein , prostate carcinoma tumor antigen 1 , 30 kDa S-type lectin , RL-30 , lectin, galactose binding, soluble 8 , galectin family xgalectin-VIIIa , xgalectin-VIII

GENE ID SPECIES
710375 Macaca mulatta
743841 Pan troglodytes
100436942 Pongo abelii
100595058 Nomascus leucogenys
56048 Mus musculus
430948 Gallus gallus
3964 Homo sapiens
479193 Canis lupus familiaris
100156193 Sus scrofa
506977 Bos taurus
116641 Rattus norvegicus
100343919 Oryctolagus cuniculus
100733991 Cavia porcellus
101115850 Ovis aries
398442 Xenopus laevis
Fournisseurs de qualité sélectionnés pour Lectin, Galactoside-Binding, Soluble, 8 (LGALS8) Kits ELISA
Avez-vous cherché autre chose?